Reddit Posts
#afterhours #watchlist 02/14 $TSEM - Intel is looking to buy Tower Semi, $IPW- earnings, $RESN -Murata to acquire Resonant for $4.50 per share in cash, $SBEV -Announces Proposed Public Offering of Common Stock , $LRMR - Update on CTI-16... Also check premarket runners and low float stocks in my app!
what is going on with Larimar Therapeutics, Inc. (LRMR)
Mentions
No, the term "diamond hands" is a euphemism to glorify stubborn bagholding, period, end of story. Nothing diamond about carrying a massive loss and losing on opportunity cost. As for $WWR, you needed to buy it before it ran, not now. No ay in hell will it go to your tartegs - the runup is over, and insiders already made money on it. My "SEC Insider Call Alerts" call option scanner picked up $WWR on 9/23/25, but I did not make any trades that day, unfortunately. I wish I did. My current trade from this set up is GCI Dec $5 calls. Here is the alert: "SEC Insider Call Alerts: • 09/23/2025, Symbol $Strike, Exp Date, Bid/Ask • 09/23/2025, GEOS $20, 10/17/2025, 1.9/2 • 09/23/2025, CGAU $10, 11/21/2025, 0.65/0.9 • 09/23/2025, LRMR $5, 10/17/2025, 1.15/1.3 • 09/23/2025, AIRS $8, 10/17/2025, 0/0.5 • 09/23/2025, AIRS $8, 01/16/2026, 0.9/2.35 • 09/23/2025, HROW $55, 11/21/2025, 3.7/4.3 **• 09/23/2025, WWR $1, 11/21/2025, 0.15/0.2** **• 09/23/2025, WWR $1, 10/17/2025, 0.1/0.15"**
Don’t worry LRMR and NVCR got me too 😉😏
Got rug pulled the other day on Larimar LRMR. Forgot the announcement was coming up and woke up to a 50% loss. Good lesson to learn
can someone explain me that huge LRMR drop?
LRMR Should release the news today! already 20 % up pre-market
Mf grocery shop TMC, LRMR. PRTA. ACHC. ABVC. ERAS. VRI. HIMS. EVGO
TMC, LRMR. PRTA. ACHC. ABVC. Thank me later Sincerely, The Chosen 1
biotech stocks with catalysts soon: LRMR - Phase 2 FBIO - PDUFA approval for first Menkes disease treatment on Sept 30th
LRMR - Quietly. No need for any post or pump and dump. Just watch for the next days.
LRMR might have its number called soon…
Larimar LRMR is through the roof today-any explanation of why?
Never Put Your Life Savings in just 1 Stock, Diversify. TOVX =300 LRMR = 200% MAIA=100% LAC = 100% LAZR=100%
Your post with title "LRMR - this one looks like it’s primed for great things." has been removed from r/pennystocks because it is too short. Posts must have at least 50 characters to ensure meaningful discussions. *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*
And of course! Larimar Therapeutics, Inc. (LRMR) is showing strong bullish momentum with a current price of $9.35, significantly above its 10-day SMA of $8.26 and 20-day EMA of $8.03, indicating a positive trend continuation. The RSI values are in the overbought territory, suggesting potential for a pullback, but the MACD histogram remains positive, supporting further upward movement. Despite low trading volume today, recent high volumes suggest increased investor interest. The broader market's robust uptrend, driven by tech sector strength, could provide additional tailwinds for LRMR. Given these factors, a long position is recommended with an entry around $9.30, targeting $9.60 and $9.80, with a stop loss at $9.00 to manage risk. Confidence in reaching the first target is moderate due to overbought conditions, while the second target carries lower confidence unless volume increases. Investors should remain vigilant for any shifts in broader market sentiment or unexpected news impacting LRMR.
ARCHR, LRMR and GME this week!!!
LRMR gonna go crazy tomorrow! 🚀🚀🚀
Now I see why my posts are getting deleted. Can someone else post that LRMR is going to the fucking 🌔🌔🌔 for me then? 🚀🚀🚀 Lol. Volume increase of 800+% AH and price up over 9% in AH. $.69 to be exact!!! LFG!!!
Shorts beginning to cover LRMR after hours. Squeeze incoming!
You got it! LRMR: Larimar Therapeutics, Inc. (LRMR) is showing promising technical strength with its current price of $7.73 above key moving averages, indicating bullish momentum. The 8-day EMA at $7.46 and a MACD histogram of 0.13 suggest continued upward pressure, supported by a 14-day RSI of 55.83, which is comfortably below overbought levels. Recent trading volumes have been consistent with the 65-day average, reflecting steady interest. Given the broader market's cautious optimism, LRMR could benefit from sector rotation into healthcare. For today's session, consider entering around $7.70, targeting $8.00 as the first price target and $8.20 as the second, with a stop loss at $7.50 to manage downside risk. Confidence in reaching the first target is moderate due to supportive technical indicators, while the second target carries lower confidence given potential market volatility. Stay vigilant for any unexpected news that could impact sentiment. LLY: Eli Lilly & Co. (LLY) is positioned for potential gains today, buoyed by recent FDA approval of its eczema drug and strategic investments in AI and manufacturing to address supply constraints. The stock has shown resilience, trading near its 20-day SMA of $906.51, with a current price of $908.47. Technical indicators suggest a neutral to slightly bullish outlook, with the MACD histogram positive and RSI levels around 49, indicating room for upward movement. Given the broader market's cautious optimism, LLY could benefit from sector strength in healthcare and technology. For today's session, consider entering around $908, targeting $915 as the first price target and $920 as the second, with a stop loss at $900 to manage downside risk. Confidence in reaching the first target is moderate, given the supportive news and technical setup, while the second target carries lower confidence due to potential market volatility. Keep an eye on volume spikes and broader market cues for confirmation of the trend.
LLY and LRMR please. Thank you!
LRMR gonna go bananas!!! 🚀🚀🚀
Do an offering goes up 40% LRMR
My picks are biotech, OCUL, ARQT, GOSS, HROW, LRMR
I run the simulator again on the 22nd with stock price 44.52. Puts 5 give a virtual 22.8 x . The play looks good. I didn't estimate at all the volatility crush in the TOS sim. And anyway Vega on the 5 puts is 0.00 . Will Vega enter as the price crushes ? Dunno. Just I have no safe way to estimate IV crush. 1) The steps in the approval process taken by $RETA 2) the steps taken by FDA in the same process seem to strengthen the short side. Also, FDA calendarized a symposium on rare diseases (like the one $RETA intends to cure) on the 27th of february, and this is the day before the PDUFA decision. Usually FDA gives indications on its policy in these occasions. This could clarify about a "shift in policy" I wrote above. 3) News COULD pop on the 27th that FDA negate any shift. Since on the medical side, this is a solid short, that will eliminate the strongest argument for longs. On that confirmation $RETA could drop, making puts expensive but also de-risking the play. ​ If you want to have puts but you want to edge the upside, I'd consider take some cheap IV 7.5 calls on $LRMR. $RETA and $LRMR are correlated.
I'm considering hedging the upside with 7.5 calls on $LRMR.
S&P500. Well I cheat. I follow hedge funds: Opaleye Management for healthcare, Duquesne Family Fund for general stocks. I check their 13F at the end of each quarter to see what they buy or sell. Also I check every week 13D or 13G to see if these funds buy or sell anything. From there I research those stocks and if the stocks have not moved much then I buy. For example TELA and LRMR is from Opaleye. The advantage of a small investor is no redemption. You can stick it out (I invest in IRA and Roth IRA). Also I don't have a lot of stocks (5 to 7). It is hard to find good stocks. Once I decided, I keep them for 6-18 months unless something goes wrong.
I always buy individual stocks. I can beat the market because I specialize in small cap. As a small investor my edge is trading in low market cap and low volume stocks. For example I own TELA and LRMR that funds don't want to bother because they cannot buy a lot of it to change their return even if the stock goes up 3x, 4x.
I am a bot. You submitted a picture of a banned ticker, LRMR. The market cap of LRMR is **205,312,300** This check will fire if you included unnecessary pictures that have bad keywords/phrases. Repost with the useless pictures omitted if you did that.
LRMR, catalyst on 11/03
>Dir Hamilton Buys 317,460 Of Larimar Therapeutics Inc $LRMR ^\*Walter ^Bloomberg ^[@DeItaone](http://twitter.com/DeItaone) ^at ^2022-09-20 ^07:53:12 ^EDT-0400
I am a bot. You submitted a picture of a banned ticker, LRMR. The market cap of LRMR is **41088240** This check will fire if you included unnecessary pictures that have bad keywords/phrases. Repost with the useless pictures omitted if you did that.
I am a bot. You submitted a picture of a banned ticker, LRMR. The market cap of LRMR is **37546150** This check will fire if you included unnecessary pictures that have bad keywords/phrases. Repost with the useless pictures omitted if you did that.
Several things might indicate that it is unlikely that RBAC = AC Milan. First, the article attached to that twitter link says: "The transition to new ownership will take place over the summer, with **an expected closing no later than September 2022**." In no SPAC universe does an unannounced multinational deal get SEC filings completed and approved in four months. Next, take a quick look at [RedBird Capital Partners' web pages](https://redbirdcap.com/). [RedBird Capital Partners Companies](https://redbirdcap.com/companies/#member-652-info) "The XFL’s ownership group, led by Dany Garcia, Dwayne Johnson, and Gerry Cardinale's **RedBird Capital Partners** ..." "On 21 July 2020, RedBird Capital Partners acquired an 85% stake in Toulouse FC" "RedBird FC is a European football & analytics platform through which RedBird deploys operating expertise and a data-analytics strategy in partnership with some of the top analytics-focused executives in sport." "Fenway Sports Group (“FSG”) is a global sports, marketing, media, entertainment, and real estate platform anchored by two iconic clubs, the Boston Red Sox and Liverpool Football Club. FSG’s portfolio includes two of the world’s most historic venues, Fenway Park and Anfield Stadium, Fenway Sports Management (“FSM”), Fenway Sports Group Real Estate (“FSGRE”), a 50% stake in NASCAR’s Roush Fenway Racing, and an 80% stake in New England Sports Network. FSM is a global sports marketing and consulting firm that represents FSG’s network of properties and serves as the exclusive marketing agency for LeBron James through a strategic partnership with LRMR Ventures. FSGRE is a private real estate firm that oversees the assets, acquisitions, and development of FSG properties." Perhaps RBAC really will be involved somehow in the AC Milan buyout, but it doesn't appear that RedBall Capital Partners needs them to be involved.
You might not believe me but around 30%. First I do research on the 13F stocks purchase. Next I toss aside the newly purchased stocks if they go up too much already. Remember at the end of each quarter say Q1 22 which is March 31 hedge fund files their 13F with 45 days delay so May 15 is the first date I can read the activity in the fund. Next I narrow down to a few stocks and do my own reasearch. I spent time learning about cost accounting for example to read 8k statement from companies. Same thing with biochemistry, genetics, etc. I skim through old textbooks to learn. I am very patient and I wait for the price to come down, sometime way lower than the hedge fund purchase price. My style is an oxymoron, searching for value in biotech. Recently I bought LRMR (I also bought AFIB even though Opaleye ditched it last quarter 21). Do your own diligence, don't take anybody word at face value.
(pt 2 - it got long, sorry!) But anyways, let's run with your definition of simple alpha and your timeframe using the 20% stop-loss and compare it against the SPY during those time periods. * NDLS - [overpeforms the SPY during the period of the grant](https://finance.yahoo.com/chart/NDLS#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). * GIII - [underperforms SPY during the period of the grant](https://finance.yahoo.com/chart/GIII#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). * WEX - over performs the SPY but those gains have been erased (couldn't link it due to character limits). * LRMR - [underperformed the SPY during the period of the grant](https://finance.yahoo.com/chart/LRMR#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-). Obviously there's something here, but what I'm looking for is some stronger signal to say: * Of these 9 stocks, invest only in these 5. * Here's how much of your portfolio you should allocate to each.
Appreciate the points. My understanding of basic alpha for investing is just Return(you) - Return(baseline). This is also what Investopedia says and the wiki bot below lol. Obviously, you can include risk (which I pointed out that I didn't) and get a more accurate picture, but I always thought that was CAPM or something. Regardless, I agree with your point that I didn't include risk and you could (or should) to get a more accurate picture. Never seen that website before, but it's pretty cool. However, the proper calculation is using the date the grant was issued as the start date for each holding (not January 1st, 2017) and then I used 3 years from the grant date as the end date (not today) because most performance grants have a 3-year expiration. If you wanted to get more specific, you should use the expiration date for each stock as the end date. In practice, you would probably want to still be even smarter and incorporate some sort of stop-loss which would (possibly) increase the overall returns and (definitely) shorten the time frame. I haven't run this specific analysis, but at a quick glance you can see that a 20% stop-loss (for example) would get you approximately the following returns for each stock $STKL - 0% returns after \~9 months $MITK - 40% returns after \~9 months $GIII - 96% returns after \~24 months $BOX - 5% returns after \~18 months $WEX - 78% returns after \~36 months $TREE - 48% returns after \~9 months $NDLS - 150% return after \~15 months $HSKA - 0% returns after \~15 months $LRMR - 50% returns after 5 months About 52% returns with an average hold length of 15 months (verses \~20% for the SPY over 15 months). Obviously, this is a really dirty way of doing any calculations, but even looking at the chart you created you see the stocks listed here crush the SPY from 2017-2019. I think your criticism still holds though. Basically, more work needs to be done to 1) eliminate noise through more data and 2) figure out better ways to calculate the returns. This post was simply the first step :)
Hey OP - first off, I love your out-of-the-box thinking here and you got me thinking about this as an exploitable strategy. One thing that I did notice though is your alpha calculation - it seems to be calculated as **Return(stock) - Return(SPY)**, which is not the entire story. Take a look at the Wikipedia page for the equation for [alpha](https://en.wikipedia.org/wiki/Alpha_%28finance%29), where you need to take into account beta and the risk-free rate (which means you need to calculate covariance of returns between the stock and the benchmark). To take it a step further, if I had a [portfolio with equal asset allocation of your suggested stocks](https://www.portfoliovisualizer.com/backtest-portfolio?s=y&timePeriod=4&startYear=2017&firstMonth=1&endYear=2021&lastMonth=12&calendarAligned=true&includeYTD=false&initialAmount=10000&annualOperation=0&annualAdjustment=0&inflationAdjusted=true&annualPercentage=0.0&frequency=4&rebalanceType=1&absoluteDeviation=5.0&relativeDeviation=25.0&leverageType=0&leverageRatio=0.0&debtAmount=0&debtInterest=0.0&maintenanceMargin=25.0&leveragedBenchmark=false&reinvestDividends=true&showYield=false&showFactors=false&factorModel=3&benchmark=-1&benchmarkSymbol=SPY&portfolioNames=false&portfolioName1=Portfolio+1&portfolioName2=Portfolio+2&portfolioName3=Portfolio+3&symbol1=STKL&allocation1_1=11&symbol2=MITK&allocation2_1=11&symbol3=GIII&allocation3_1=11&symbol4=BOX&allocation4_1=11&symbol5=WEX&allocation5_1=11&symbol6=TREE&allocation6_1=11&symbol7=NDLS&allocation7_1=11&symbol8=HSKA&allocation8_1=11&symbol9=LRMR&allocation9_1=12), I'd actually underperform the SPY (alpha of -4%). If, with the benefit of hindsight, [this is the ideal asset allocation with an alpha of ~16%](https://www.portfoliovisualizer.com/optimize-portfolio?s=y&goal=2&benchmark=-1&benchmarkSymbol=SPY&constrained=true&symbol5=WEX&symbol4=BOX&lastMonth=12&historicalVolatility=true&symbol7=NDLS&symbol6=TREE&symbol1=STKL&endYear=2021&symbol3=GIII&symbol2=MITK&mode=2&comparedAllocation=-1&startYear=2017&symbol9=LRMR&symbol8=HSKA&timePeriod=4&historicalReturns=true&robustOptimization=false&historicalCorrelations=true&firstMonth=1&groupConstraints=false) * How would I know to overweight MITK and BOX, given that one CEO reached their goal and one didn't? * How would I know not to allocate anything to LRMR and WEX, given on paper, they seemed to have crushed it based on that table?
LRMR and SENS both at a low point with huge growth potential!
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: LRMR. Message /u/zjz if they're above 1.25 billion-ish market cap and not related to crypto/pennies/OTC/SPACs.
Amc up 7% GME up 8% and LRMR UP 18% since this morning. Yall called me dumb for the lrmr
I loved LRMR at $7, new low for the year. It's already back at $9 with a 52 week high of about $26. I'll be happy if it reaches $15 again which it probably will. Good deal
Sorry. Was checking my LRMR. lol it went up again
OK so there's gme, right? And then there's AMC, RIGHT? and then theres...LRMR! This shit is about to take offffff
Should've put some towards LRMR.
LRMR up 6% after hitting its 52 week low. Great time to get in now that we'll probably all be trying to make up for our amc and gme bags
LRMR!! I bought a bunch pre market today because it was at a new 52 week low! It's already going back up big! What a good day. Ima hold because it's so far away from it's 52 week high.
lmao who would've thought that buying dips of failing bio-tech companies would be my most profitable strategy? xD #LRMR
LRMR ( est. 2005 ) is at $7.76. 52 week low is $7. 52 week high is $26. Buy it up while it's cheap